Pediatrix Medical Group, Inc. (NYSE:MD) Receives Consensus Rating of “Hold” from Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) have received a consensus recommendation of “Hold” from the six brokerages that are currently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $23.3333.

A number of analysts recently weighed in on the stock. Jefferies Financial Group restated a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a research note on Monday, April 20th. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research report on Friday, May 8th. Truist Financial raised their price objective on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a report on Tuesday. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research report on Wednesday, June 24th. Finally, UBS Group increased their target price on Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th.

Insider Activity

In other news, Director Shirley A. Weis sold 36,028 shares of the stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Pediatrix Medical Group

Institutional investors have recently added to or reduced their stakes in the business. Phocas Financial Corp. lifted its position in shares of Pediatrix Medical Group by 44.5% during the 4th quarter. Phocas Financial Corp. now owns 335,551 shares of the company’s stock worth $7,177,000 after buying an additional 103,328 shares during the last quarter. Ritholtz Wealth Management acquired a new stake in Pediatrix Medical Group during the 4th quarter worth $2,163,000. Allspring Global Investments Holdings LLC purchased a new stake in Pediatrix Medical Group in the fourth quarter valued at $13,613,000. CSM Advisors LLC boosted its stake in Pediatrix Medical Group by 54.7% in the third quarter. CSM Advisors LLC now owns 313,675 shares of the company’s stock valued at $5,253,000 after acquiring an additional 110,877 shares in the last quarter. Finally, Teacher Retirement System of Texas grew its holdings in shares of Pediatrix Medical Group by 25.6% during the fourth quarter. Teacher Retirement System of Texas now owns 306,715 shares of the company’s stock worth $6,561,000 after purchasing an additional 62,446 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 1.6%

NYSE:MD opened at $26.29 on Friday. Pediatrix Medical Group has a 12-month low of $11.84 and a 12-month high of $27.94. The firm has a market cap of $2.16 billion, a PE ratio of 12.76 and a beta of 0.66. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45. The stock has a fifty day moving average price of $23.86 and a 200 day moving average price of $22.16.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. The company had revenue of $476.20 million for the quarter, compared to the consensus estimate of $465.83 million. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.Pediatrix Medical Group’s revenue was up 3.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.33 EPS. Sell-side analysts anticipate that Pediatrix Medical Group will post 2.1 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.